NCT07441291
- Conditions
- Allogenetic Hematopoietic Stem Cell Transplantation, B ALL, MRD-positive, +5 more
- Locations
-
- Peking University People's Hospital Beijing, China
Clinical trial condition
Neoplasm, Residual
Explore clinical trials studying Neoplasm, Residual. Study availability and eligibility vary by location and protocol.
207 public trials
79 recruiting studies
Neoplasm, Residual trial results
NCT07148180
- Conditions
- Acute Myeloid Leukaemia (AML), Blood Cancer, Blood Cancers, +13 more
- Locations
-
- Brigham and Women's Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT06693830
- Conditions
- Diffuse Large B Cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, +15 more
- Locations
-
- Columbia University New York, United States
NCT07356882
- Conditions
- Classical Hodgkin Lymphoma, Neoplasm, Residual, Neoplasms, +3 more
- Locations
-
- Pediatric Hematology and Oncology Department Paris, France
Recruiting
Caris Biorepository Research Protocol
NCT01499394
- Conditions
- Cancer, Early Detection of Cancer, Minimal Residual Disease, +5 more
- Locations
-
- University of South Alabama Mobile, Alabama, United States
- Southwest Medical Imaging Scottsdale, Arizona, United States
- St. Bernards Medical Center Jonesboro, Arkansas, United States
- CARTI Cancer Center Little Rock, Arkansas, United States
Recruiting
Minimal Residual Disease Response-adapted Deferral of Transplant in Dysproteinemia (MILESTONE)
NCT04991103
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +20 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
Recruiting
To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT
NCT07280494
- Conditions
- CD7+ T-ALL/LBL, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Peking University People's Hospital Beijing, China
NCT05595408
- Conditions
- Muscle Invasive Upper Tract Urothelial Carcinoma, Neoplasm, Residual, Neoplasms, +3 more
- Locations
-
- Renji Hospital Shanghai, Shanghai Municipality, China
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Wilmot Cancer Institute Rochester, New York, United States
NCT01898039
- Conditions
- Malignant Melanoma, Melanoma, Neoplasm, Residual, +14 more
- Locations
-
- Sharett Institute of Oncology, Hadassah Medical Organization Jerusalem, Israel